SHINE Technologies
SHINE Technologies is a fusion-based isotope company that produces non-carrier-added Lu-177 (Ilumira) and is building the Chrysalis Mo-99 plant.
Overview
SHINE Technologies, based in Janesville, Wisconsin, is a fusion-based isotope company that produces non-carrier-added lutetium-177, sold as Ilumira, and is building the Chrysalis molybdenum-99 plant. It has supplied lutetium-177 to radiopharmaceutical developers since 2022, its large-scale Mo-99 facility is under construction, and it holds long-term fusion energy ambitions. Nuclide links it to the therapeutic isotope supply chain for Mo-99, Lu-177 and Ac-225. Whether a second Western source of lutetium-177 makes supply resilient enough for radioligand therapy to scale is the open question. The isotope supply chain page carries the wider picture.
Manufacturing
Capacity map- SHINE Technologies Janesville Janesville, Wisconsin, USRadioisotope production
Similar pages
not linked directly; found by shared links- CompanyNorthStar Medical Radioisotopes
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag supporting.
- CompanyANSTO (Australian Nuclear Science and Technology Organisation)
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
- CompanyEckert & Ziegler
Shares Research reactors for medical isotopes (Mo-99, Lu-177, I-131), Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Actinium-225, Lutetium-177 and the tag supporting.
- CompanyNTP Radioisotopes
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
- CompanyNordion (Sotera Health)
Shares Molybdenum-99 supply, Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131).
- TechnologyRadiopharmacy and cyclotron networks
Shares Isotope supply roadmap: reactor dependence → non-uranium production → accelerator-made actinium, Research reactors for medical isotopes (Mo-99, Lu-177, I-131), Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225), Actinium-225 and the tag supporting.
- TechnologyRadionuclide generators and cold kits
Shares Molybdenum-99 supply, Molybdenum-99, Research reactors for medical isotopes (Mo-99, Lu-177, I-131) and the tag supporting.
- CompanyTrasis
Shares Lutetium-177 and the tag supporting.